Two forces are tightening around US startups at once, and they are pulling in opposite directions for founders. Capital is concentrating ever more heavily in California, according to Crunchbase data, while the personal consequences of misrepresenting a company to investors are becoming clearer, as the Joonko guilty plea shows. Meanwhile, the tools startups sell to enterprises are being judged on whether they produce measurable proof, the premise behind Colare's simulation-based hiring product. The common thread is verification: investors, customers and now prosecutors all want evidence, and the founders who supply it cleanly will be the ones who can raise, sell and survive.
The California concentration
Crunchbase News reports that California startups have raised more than three-fourths of all US startup funding in 2026, an apparent record share, with a couple of months still left in the year. That is not merely a bragging point for one state. It describes a national market in which the overwhelming majority of institutional startup capital is flowing to companies clustered in a single geography, and it raises the stakes of every decision made inside those companies.
For US technology companies outside California, the implication is structural. A founder in another state competing for the same limited pool of venture dollars is now competing against a market that absorbs the large majority of it. That pressure can push founders toward aggressive positioning: bigger customer claims, grander revenue projections, broader AI capabilities. The concentration story and the misconduct story are not separate; scarcity and hype tend to travel together.
What the Joonko plea signals
In a guest piece for Crunchbase News, Kyle Jeziorski of Founder Shield writes that false claims about customers, revenue and AI capabilities can expose founders to personal securities-fraud liability, and that D&O insurance offers limited protection against established misconduct. He highlights three policy provisions founders should examine closely. The piece is framed around the Joonko guilty plea, and its central warning is direct: misrepresentation is not a company problem that a policy absorbs, but a personal one.
For US founders, that reframes the fundraising conversation. The pitch deck is not marketing copy; it is a representation made to investors, and the distance between what a startup claims and what it can document is where legal exposure lives. The specific categories Jeziorski names, customers, revenue and AI capabilities, are precisely the categories that have been most inflated across the startup market in recent years. The lesson is not that founders should be timid, but that every material claim in a raise needs a record behind it.
Selling proof to enterprise buyers
Colare's $2.5 million pre-seed round, backed by Afore Capital, Garage Capital and Acadian Ventures as SiliconANGLE reported, points at the same demand from the other side of the table. The company has built a simulation-based technical screening platform that companies can use to assess an engineering candidate's ability, and it says the platform is ready for prime time today. The product exists because enterprise buyers no longer want to take a resume, or a vendor's word, at face value.
That is a small round, but it is a useful signal. Hiring is one of the few budget lines where companies can still justify new spend if the tool produces observable results, and a simulation produces exactly that: a candidate's performance rather than a candidate's description of it. The same logic is spreading across enterprise software purchasing, where buyers increasingly want a trial, a benchmark or a reference before they sign. Startups selling verification are selling into a market that has been trained to be skeptical.
